$NMUS This is where I expect some of the $20 million funding will probably go.... NEMUS plans on advancing testing of NB1111 into a second animal model and hold a pre-Investigational New Drug (IND) meeting with the FDA The company has been approached by a number of manufacturers of sustained delivery devices and anticipates identifying a compatible technology
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.